BSE filing, NSE: SEKURITIND. Summary written from the filing by ALFA Finder's alert engine.
Saint-Gobain Sekurit India Ltd: key numbers
- Share price
- ₹103.85
- Market cap
- ₹946.1 Cr
- Revenue (annual)
- ₹243.0 Cr
- Net profit (annual)
- ₹45.80 Cr
- P/E (TTM)
- 21.3×Sector 31.4×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saint-Gobain Sekurit India Ltd
All →Saint-Gobain Sekurit India Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI (LODR) Regulations for the quarter ended September 30, 2026.
Saint-Gobain Sekurit India Board Meeting Date
Saint-Gobain Sekurit India scheduled its Board Meeting for 02 Nov 2026 to approve unaudited Q2/H1 FY27 results. No financial figures or outcomes are disclosed at this stage.
Saint-Gobain Sekurit India Annual General Meeting
Saint-Gobain Sekurit India Limited held its 53rd Annual General Meeting on July 30, 2026. All resolutions listed in the AGM notice were successfully passed by shareholders.
Saint-Gobain Sekurit India Q1 FY27 Results: Net Profit ₹9.3 Cr, Down 13.1% YoY
Saint-Gobain Sekurit India Ltd reported revenue from operations of ₹60.8 Cr (+10.9% YoY) and net profit of ₹9.3 Cr (-13.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹9.3 Cr · -13.1% YoY
Saint-Gobain Sekurit India Business Update
Saint-Gobain Sekurit India Ltd filed its quarterly shareholding pattern. The disclosure outlines holdings across promoters, institutional and retail investors.
Saint-Gobain Sekurit India Business Update
Saint-Gobain Sekurit India filed its FY 2025-26 Business Responsibility and Sustainability Report along with the Annual Report. The AGM notice caps related‑party transactions at Rs 150 Crore.
- Value
- ₹150.2 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.